Figure 1
![Figure 1](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2F1748-717X-7-142/MediaObjects/13014_2012_Article_664_Fig1_HTML.jpg)
Overall survival in patients treated with late course of accelerated hyperfractionated irradiation (LCAF) alone (dashed line) or LCAF with concurrent chemotherapy (LCAF + CT) (solid line).
Overall survival in patients treated with late course of accelerated hyperfractionated irradiation (LCAF) alone (dashed line) or LCAF with concurrent chemotherapy (LCAF + CT) (solid line).